1/2
06:27 pm
aplt
Form 4 Applied Therapeutics, For: Jan 01 Filed by: Funtleyder Leslie D.
Medium
Report
Form 4 Applied Therapeutics, For: Jan 01 Filed by: Funtleyder Leslie D.
12/31
12:30 pm
aplt
Form SCHEDULE 13G/A Applied Therapeutics, Filed by: Propel Bio Management, LLC
Medium
Report
Form SCHEDULE 13G/A Applied Therapeutics, Filed by: Propel Bio Management, LLC
12/29
04:34 pm
aplt
Form SC 14D9 Applied Therapeutics, Filed by: Applied Therapeutics, Inc.
Medium
Report
Form SC 14D9 Applied Therapeutics, Filed by: Applied Therapeutics, Inc.
12/29
10:14 am
aplt
Form SC TO-T Applied Therapeutics, Filed by: AT2B, Inc.
High
Report
Form SC TO-T Applied Therapeutics, Filed by: AT2B, Inc.
12/18
03:14 pm
aplt
Form 4 Applied Therapeutics, For: Dec 16 Filed by: Kanter Stacy J.
Neutral
Report
Form 4 Applied Therapeutics, For: Dec 16 Filed by: Kanter Stacy J.
12/16
11:05 am
aplt
Form 144 Applied Therapeutics, Filed by: Kanter Stacy J.
Medium
Report
Form 144 Applied Therapeutics, Filed by: Kanter Stacy J.
12/15
05:38 pm
aplt
Form SCHEDULE 13G/A Applied Therapeutics, Filed by: ALEXANDRIA REAL ESTATE EQUITIES, INC.
Medium
Report
Form SCHEDULE 13G/A Applied Therapeutics, Filed by: ALEXANDRIA REAL ESTATE EQUITIES, INC.
12/12
06:02 am
aplt
Form 8-K Applied Therapeutics, For: Dec 11
High
Report
Form 8-K Applied Therapeutics, For: Dec 11
12/12
06:02 am
aplt
Form SC14D9C Applied Therapeutics, Filed by: Applied Therapeutics, Inc.
High
Report
Form SC14D9C Applied Therapeutics, Filed by: Applied Therapeutics, Inc.
11/20
08:04 am
aplt
Form 8-K Applied Therapeutics, For: Nov 20
Medium
Report
Form 8-K Applied Therapeutics, For: Nov 20
11/14
12:19 pm
aplt
Form SCHEDULE 13G/A Applied Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
High
Report
Form SCHEDULE 13G/A Applied Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
11/13
07:16 am
aplt
Form 10-Q Applied Therapeutics, For: Sep 30
High
Report
Form 10-Q Applied Therapeutics, For: Sep 30
11/13
07:11 am
aplt
Form 8-K Applied Therapeutics, For: Nov 09
High
Report
Form 8-K Applied Therapeutics, For: Nov 09